Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-11

Clinical Trial Update: The Impact of Riboflavin on the Severity and Duration of Sports Related Concussion [NA]

View source ↗

Summary

A completed clinical trial evaluating riboflavin (vitamin B2) for its effect on the severity and duration of sports-related concussion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riboflavin (Vitamin B2) (riboflavin)

Snippet

Sponsor: University of Virginia | Conditions: Sports Related Concussion | NA | Status: COMPLETED